Hereditary Spastic Paraparesis Clinical Trial
Official title:
SNAP: Measurement of the Subjective Perception of the Symptom in Hereditary Spastic Paraparesis (HSP)
NCT number | NCT04256681 |
Other study ID # | GIP 595 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 30, 2018 |
Est. completion date | May 31, 2021 |
Verified date | November 2021 |
Source | IRCCS Eugenio Medea |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Self-Notion and Perception (SNAP) questionnaire developed at IRCCS E.Medea by Eleonora Diella and Roberta Morganti, arises from the need to quantify the subjective perception of the patient suffering from HSP of the typical symptoms of pathology, such as spasticity, weakness, changes in balance, resistance in walking, pain and fatigue. The purpose of this study is to validate this instrument and test its reliability, looking for correlations with the measurement scales used in the literature for the evaluation of the patient with HSP. The most used for this population are the Spastic Paraplegia Rating Scale (SPRS) and the Six-Minute Walk Test (6MWT) which assess the severity of the disease and the level of endurance (8-9) respectively.
Status | Completed |
Enrollment | 80 |
Est. completion date | May 31, 2021 |
Est. primary completion date | May 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 9 Years and older |
Eligibility | Inclusion Criteria: - diagnosis of genetically determined hereditary spastic paraparesis or subjects without defined genetics but who unequivocally show at the time of evaluation a dominant or recessive familiarity with exclusive involvement of the pyramidal system - age> 9 years - IQ> 80 - The patient must be able to walk for at least 10 meters. Indoors, even with help Exclusion Criteria: - Age less than 9 years - IQ <80, - loss of gait - psychopathological aspects that can affect the validity of the data collected |
Country | Name | City | State |
---|---|---|---|
Italy | Eleonora Diella | Bosisio Parini |
Lead Sponsor | Collaborator |
---|---|
IRCCS Eugenio Medea |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Test the validity, investigating the correlation with Spastic Paraplegia Rating Scale and with Six-Minute Walk Test, and the reliability (through test-retest mode) of the SNAP questionnaire in the aforementioned population. | the Spastic Paraplegia Rating Scale (SPRS) and the Six-Minute Walk Test (6MWT) which assess the severity of the disease and the level of endurance respectively. | 2 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04768166 -
Testing Miglustat Administration in Subjects With Spastic Paraplegia 11
|
Phase 2 | |
Recruiting |
NCT06229626 -
Evaluation of an Intensive Training Program for Patients With Hereditary Spastic Paraparesis SPG4/Spast
|
N/A | |
Completed |
NCT00677768 -
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
|
N/A |